These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11518490)

  • 41. Secretin for autism? Not so fast.
    Health News; 2000 Feb; 6(2):6. PubMed ID: 10734825
    [No Abstract]   [Full Text] [Related]  

  • 42. Secretin: cure or snake oil for autism in the new millennium? (response).
    Herlihy WC
    J Pediatr Gastroenterol Nutr; 2000 Feb; 30(2):112-3; author reply 113-4. PubMed ID: 10697126
    [No Abstract]   [Full Text] [Related]  

  • 43. Secretin: cure or snake oil for autism in the new millennium?
    Lightdale JR; Heyman MB
    J Pediatr Gastroenterol Nutr; 1999 Aug; 29(2):114-5. PubMed ID: 10435643
    [No Abstract]   [Full Text] [Related]  

  • 44. Secretin treatment for autistic disorder: a critical analysis.
    Patel NC; Yeh JY; Shepherd MD; Crismon ML
    Pharmacotherapy; 2002 Jul; 22(7):905-14. PubMed ID: 12126223
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Secretin treatment of autism?].
    Jørgensen M; Thomsen PH; Henriksen JH
    Ugeskr Laeger; 2002 Mar; 164(12):1676. PubMed ID: 11924292
    [No Abstract]   [Full Text] [Related]  

  • 46. Novel treatments for autistic spectrum disorders.
    Levy SE; Hyman SL
    Ment Retard Dev Disabil Res Rev; 2005; 11(2):131-42. PubMed ID: 15977319
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Secretin treatment for autism.
    Horvath K
    N Engl J Med; 2000 Apr; 342(16):1216; author reply 1218. PubMed ID: 10777376
    [No Abstract]   [Full Text] [Related]  

  • 48. Intravenous secretin for autism spectrum disorder.
    Williams KW; Wray JJ; Wheeler DM
    Cochrane Database Syst Rev; 2005 Jul; (3):CD003495. PubMed ID: 16034901
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Secretin treatment for autism.
    Rimland B
    N Engl J Med; 2000 Apr; 342(16):1216-7; author reply 1218. PubMed ID: 10777377
    [No Abstract]   [Full Text] [Related]  

  • 50. Secretin treatment for autism.
    Said SI; Bodanszky M
    N Engl J Med; 2000 Apr; 342(16):1217-8. PubMed ID: 10777379
    [No Abstract]   [Full Text] [Related]  

  • 51. Commentary: the primacy of the scientific method.
    Tanguay PE
    J Am Acad Child Adolesc Psychiatry; 2002 Nov; 41(11):1322-3. PubMed ID: 12410074
    [No Abstract]   [Full Text] [Related]  

  • 52. Re: Secretin and autism: a two-part clinical investigation.
    Clark CE
    J Autism Dev Disord; 2001 Apr; 31(2):248-9. PubMed ID: 11450825
    [No Abstract]   [Full Text] [Related]  

  • 53. RG-1068 RepliGen.
    Wheeler G
    Curr Opin Investig Drugs; 2003 Jan; 4(1):66-71. PubMed ID: 12625032
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Placebo effects in autism: lessons from secretin.
    Sandler AD; Bodfish JW
    J Dev Behav Pediatr; 2000 Oct; 21(5):347-50. PubMed ID: 11064962
    [No Abstract]   [Full Text] [Related]  

  • 55. Desperate for an autism cure.
    Shute N
    Sci Am; 2010 Oct; 303(4):80-5. PubMed ID: 20923134
    [No Abstract]   [Full Text] [Related]  

  • 56. Inositol treatment of autism.
    Levine J; Aviram A; Holan A; Ring A; Barak Y; Belmaker RH
    J Neural Transm (Vienna); 1997; 104(2-3):307-10. PubMed ID: 9203092
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lessons from secretin.
    Volkmar FR
    N Engl J Med; 1999 Dec; 341(24):1842-4. PubMed ID: 10588973
    [No Abstract]   [Full Text] [Related]  

  • 58. Administration of secretin for autism alters dopamine metabolism in the central nervous system.
    Toda Y; Mori K; Hashimoto T; Miyazaki M; Nozaki S; Watanabe Y; Kuroda Y; Kagami S
    Brain Dev; 2006 Mar; 28(2):99-103. PubMed ID: 16168596
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Secretin: real therapeutic potential (response).
    Rimland B
    J Pediatr Gastroenterol Nutr; 2000 Feb; 30(2):113; author reply 113-4. PubMed ID: 10697127
    [No Abstract]   [Full Text] [Related]  

  • 60. Secretin in a patient with treatment-resistant schizophrenia and prominent autistic features.
    Alamy SS; Jarskog LF; Sheitman BB; Lieberman JA
    Schizophr Res; 2004 Feb; 66(2-3):183-6. PubMed ID: 15061252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.